Market Tracker

01/22 6:55am ET

Edwards Lifesciences Corp (NYSE:EW)

123.91
Delayed Data
As of Jan 19
 +2.19 / +1.80%
Today’s Change
86.55
Today|||52-Week Range
124.10
+9.94%
Year-to-Date
Wendell David Associates Inc Buys iShares U.S. ...
Jan 16 / GuruFocus News - Paid Partner Content
7 Quality Stocks in Gurus' Portfolios
Jan 16 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close121.72
Today’s open122.05
Day’s range121.86 - 124.10
Volume1,255,480
Average volume (3 months)1,462,216
Market cap$26.2B
Data as of 4:01pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)+16.00%
Earnings growth (this year)+30.05%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+18.85%
P/E ratio36.1
Price/Sales6.89
Price/Book10.01

Competitors

 Today’s
change
Today’s
% change
SNNSmith & Nephew PLC+0.27+0.78%
ISRGIntuitive Surgical+1.16+0.27%
STESTERIS plc+0.53+0.58%
HRCHill-Rom Holdings In...+1.50+1.71%
Data as of 4:02pm ET, 01/19/2018

Financials

Next reporting dateFebruary 2, 2018
EPS forecast (this quarter)$0.91
Annual revenue (last year)$3.0B
Annual profit (last year)$569.5M
Net profit margin19.22%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Michael A. Mussallem
Chief Financial Officer &
Vice President
Scott B. Ullem
Corporate headquarters
Irvine, California

Forecasts